These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 15674109)
1. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Schmidt C; Giese T; Ludwig B; Mueller-Molaian I; Marth T; Zeuzem S; Meuer SC; Stallmach A Inflamm Bowel Dis; 2005 Jan; 11(1):16-23. PubMed ID: 15674109 [TBL] [Abstract][Full Text] [Related]
2. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases. Verdier J; Begue B; Cerf-Bensussan N; Ruemmele FM Inflamm Bowel Dis; 2012 Jul; 18(7):1260-6. PubMed ID: 21994045 [TBL] [Abstract][Full Text] [Related]
3. The expression of IL-12 p40 and its homologue, Epstein-Barr virus-induced gene 3, in inflammatory bowel disease. Omata F; Birkenbach M; Matsuzaki S; Christ AD; Blumberg RS Inflamm Bowel Dis; 2001 Aug; 7(3):215-20. PubMed ID: 11515847 [TBL] [Abstract][Full Text] [Related]
4. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients. Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889 [TBL] [Abstract][Full Text] [Related]
5. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-18 is increased only in a minority of patients with active Crohn's disease. Schmidt C; Giese T; Goebel R; Schilling M; Marth T; Ruether A; Schreiber S; Zeuzem S; Meuer SC; Stallmach A Int J Colorectal Dis; 2007 Sep; 22(9):1013-20. PubMed ID: 17318554 [TBL] [Abstract][Full Text] [Related]
7. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898 [TBL] [Abstract][Full Text] [Related]
8. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Fuss IJ; Becker C; Yang Z; Groden C; Hornung RL; Heller F; Neurath MF; Strober W; Mannon PJ Inflamm Bowel Dis; 2006 Jan; 12(1):9-15. PubMed ID: 16374252 [TBL] [Abstract][Full Text] [Related]
9. An interleukin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn's disease. Christ AD; Stevens AC; Koeppen H; Walsh S; Omata F; Devergne O; Birkenbach M; Blumberg RS Gastroenterology; 1998 Aug; 115(2):307-13. PubMed ID: 9679036 [TBL] [Abstract][Full Text] [Related]
10. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease. Nielsen OH; Rüdiger N; Gaustadnes M; Horn T Scand J Gastroenterol; 1997 Oct; 32(10):1028-34. PubMed ID: 9361176 [TBL] [Abstract][Full Text] [Related]
11. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Mullin GE; Lazenby AJ; Harris ML; Bayless TM; James SP Gastroenterology; 1992 May; 102(5):1620-7. PubMed ID: 1568572 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol. Gologan S; Iacob R; Iancu D; Iacob S; Cotruta B; Vadan R; Catuneanu AM; Constantinescu I; Barbarii L; Gheorghe C; Diculescu M J Crohns Colitis; 2013 Sep; 7(8):622-30. PubMed ID: 23014361 [TBL] [Abstract][Full Text] [Related]
13. Increased synthesis and intestinal expression of IL-39 in patients with inflammatory bowel disease. Fonseca-Camarillo G; Furuzawa-Carballeda J; Barreto-Zúñiga R; Martínez-Benítez B; Yamamoto-Furusho JK Immunol Res; 2024 Apr; 72(2):284-292. PubMed ID: 37968544 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease. Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990 [TBL] [Abstract][Full Text] [Related]
20. High intestinal and systemic levels of interleukin-23/T-helper 17 pathway in Chinese patients with inflammatory bowel disease. Song L; Zhou R; Huang S; Zhou F; Xu S; Wang W; Yi F; Wang X; Xia B Mediators Inflamm; 2013; 2013():425915. PubMed ID: 24382939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]